| 产品描述: | AT2 receptor agonist C21 是一种类似药物的,选择性 angiotensin II AT2 receptor (血管紧张素 II AT2 受体)激动剂,对 AT2 受体和 AT1 受体的 Ki 值分别为 0.4 nM 和 10 µM。 |
| 靶点: |
RAAS |
| 体内研究: |
AT2 receptor agonist C21, with a bioavailability of 20-30% after oral administration and a half-life estimated to 4 h in rat, induces outgrowth of neurite cells, stimulates p42/p44mapk, enhances in vivo duodenal alkaline secretion in Sprague-Dawley rats, and lowers the mean arterial blood pressure in anesthetized, spontaneously hypertensive rats[1]. |
| 参考文献: |
[1]. Wan Y, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem. 2004 Nov 18;47(24):5995-6008. [Content Brief]
[2]. Schwengel K, Namsolleck P, Lucht K, et al. Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice. J Mol Med (Berl). 2016;94(8):957-966. [Content Brief]
[3]. Fatima N, Patel S, Hussain T. Angiotensin AT2 Receptor is Anti-inflammatory and Reno-Protective in Lipopolysaccharide Mice Model: Role of IL-10. Front Pharmacol. 2021;12:600163. [Content Brief] |
| 溶解性: |
DMSO : 100 mg/mL (210.25 mM; Need ultrasonic) |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.103 ml |
10.513 ml |
21.025 ml |
| 5 mM |
0.421 ml |
2.103 ml |
4.205 ml |
| 10 mM |
0.21 ml |
1.051 ml |
2.103 ml |
| 50 mM |
0.042 ml |
0.21 ml |
0.421 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |